EIC
Elicera Therapeutics receives partial payment of 0,5 MEUR from EIC
Cell and gene therapy company Elicera Therapeutics has received a EUR 500 tranche from the European Innovation Council (EIC) within...
Well-funded Elicera prepared for clinic and business development
Cell and gene therapy company Elicera Therapeutics has made important...
Advancement in Eliceras 2022 opens up for intensive clinical year
In 2022, Elicera Therapeutics advanced – the only...
Elicera receives funding for clinical studies with ELC-301
Gene therapy company Elicera Therapeutics has been awarded 2,5 million Euros...